Molecular Dynamics Simulations Suggest Ligand’s Binding to Nicotinamidase/Pyrazinamidase
暂无分享,去创建一个
Qing-Chuan Zheng | Qingchuan Zheng | Hong-Xing Zhang | Hong-Xing Zhang | Ji-Long Zhang | Zheng-Qiang Li | Zheng-Qiang Li | Jilong Zhang
[1] G. Magni,et al. Enzymology of NAD+ synthesis. , 1999, Advances in enzymology and related areas of molecular biology.
[2] D. Mitchison,et al. The curious characteristics of pyrazinamide: a review. , 2003, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[3] W. L. Jorgensen,et al. Comparison of simple potential functions for simulating liquid water , 1983 .
[4] B. Brooks,et al. Constant pressure molecular dynamics simulation: The Langevin piston method , 1995 .
[5] C. Chipot,et al. Overcoming free energy barriers using unconstrained molecular dynamics simulations. , 2004, The Journal of chemical physics.
[6] A. Sauve,et al. Characterization of nicotinamidases: steady state kinetic parameters, classwide inhibition by nicotinaldehydes, and catalytic mechanism. , 2010, Biochemistry.
[7] Ying Zhang,et al. Pyrazinamide Inhibits Trans-Translation in Mycobacterium tuberculosis , 2011, Science.
[8] M. Hirata,et al. pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis clinical isolates from the southeast region of Brazil. , 2006, The Journal of antimicrobial chemotherapy.
[9] M. A. Steele,et al. The role of pyrazinamide in tuberculosis chemotherapy. , 1988, Chest.
[10] I. Sugawara,et al. Overview of anti-tuberculosis (TB) drugs and their resistance mechanisms. , 2007, Mini reviews in medicinal chemistry.
[11] S. Cameron,et al. Specificity and mechanism of Acinetobacter baumanii nicotinamidase: implications for activation of the front-line tuberculosis drug pyrazinamide. , 2009, Angewandte Chemie.
[12] T. Darden,et al. Particle mesh Ewald: An N⋅log(N) method for Ewald sums in large systems , 1993 .
[13] C. Brenner,et al. NAD+ metabolism in health and disease. , 2007, Trends in biochemical sciences.
[14] Alexander D. MacKerell,et al. CHARMM general force field: A force field for drug‐like molecules compatible with the CHARMM all‐atom additive biological force fields , 2009, J. Comput. Chem..
[15] D. Gigot,et al. Pre‐B‐cell colony‐enhancing factor, whose expression is up‐regulated in activated lymphocytes, is a nicotinamide phosphoribosyltransferase, a cytosolic enzyme involved in NAD biosynthesis , 2002, European journal of immunology.
[16] K. Schulten,et al. Free energy calculation from steered molecular dynamics simulations using Jarzynski's equality , 2003 .
[17] Li-Jun Bi,et al. Characterization of Mycobacterium tuberculosis nicotinamidase/pyrazinamidase , 2008, The FEBS journal.
[18] A. Zaha,et al. Characterization of pncA Mutations in Pyrazinamide-Resistant Mycobacterium tuberculosis in Brazil , 2005, Antimicrobial Agents and Chemotherapy.
[19] J. Moniz-Pereira,et al. pncA Mutations in Pyrazinamide-Resistant Mycobacterium tuberculosis Isolates in Portugal , 2004, Antimicrobial Agents and Chemotherapy.
[20] R. Gilman,et al. Effect of pyrazinamidase activity on pyrazinamide resistance in Mycobacterium tuberculosis. , 2009, Tuberculosis.
[21] J. Board,et al. Ewald summation techniques in perspective: a survey , 1996 .
[22] Qing-Chuan Zheng,et al. Unbinding of glucose from human pulmonary surfactant protein D studied by steered molecular dynamics simulations , 2010 .
[23] Mark D'Souza,et al. From Genetic Footprinting to Antimicrobial Drug Targets: Examples in Cofactor Biosynthetic Pathways , 2002, Journal of bacteriology.
[24] Alexander D. MacKerell,et al. All-atom empirical potential for molecular modeling and dynamics studies of proteins. , 1998, The journal of physical chemistry. B.
[25] C. Jarzynski. Equilibrium free-energy differences from nonequilibrium measurements: A master-equation approach , 1997, cond-mat/9707325.
[26] K. Schulten,et al. Calculating potentials of mean force from steered molecular dynamics simulations. , 2004, The Journal of chemical physics.
[27] D. Osei-Hyiaman,et al. Molecular characterization of pncA gene mutations in Mycobacterium tuberculosis clinical isolates from China , 2000, Epidemiology and Infection.
[28] Thomas Speck,et al. Distribution of work in isothermal nonequilibrium processes. , 2004, Physical review. E, Statistical, nonlinear, and soft matter physics.
[29] D. Schnappinger,et al. Biosynthesis and Recycling of Nicotinamide Cofactors in Mycobacterium tuberculosis , 2008, Journal of Biological Chemistry.
[30] S. Norris,et al. A plasmid‐encoded nicotinamidase (PncA) is essential for infectivity of Borrelia burgdorferi in a mammalian host , 2003, Molecular microbiology.
[31] W. Sougakoff,et al. Crystal Structure of the Pyrazinamidase of Mycobacterium tuberculosis: Insights into Natural and Acquired Resistance to Pyrazinamide , 2011, PloS one.
[32] Hoover,et al. Canonical dynamics: Equilibrium phase-space distributions. , 1985, Physical review. A, General physics.
[33] A. Sauve. NAD+ and Vitamin B3: From Metabolism to Therapies , 2008, Journal of Pharmacology and Experimental Therapeutics.
[34] K Schulten,et al. VMD: visual molecular dynamics. , 1996, Journal of molecular graphics.
[35] Laxmikant V. Kalé,et al. Scalable molecular dynamics with NAMD , 2005, J. Comput. Chem..
[36] F. Portaels,et al. Relationship between Pyrazinamide Resistance, Loss of Pyrazinamidase Activity, and Mutations in the pncA Locus in Multidrug-Resistant Clinical Isolates of Mycobacterium tuberculosis , 1999, Antimicrobial Agents and Chemotherapy.
[37] W. Mcdermott,et al. Pyrazinamide susceptibility and amidase activity of tubercle bacilli. , 1967, The American review of respiratory disease.
[38] C. Jarzynski. Nonequilibrium Equality for Free Energy Differences , 1996, cond-mat/9610209.
[39] S H Kim,et al. Crystal structure and mechanism of catalysis of a pyrazinamidase from Pyrococcus horikoshii. , 2001, Biochemistry.
[40] D. Zuckerman,et al. Efficient use of nonequilibrium measurement to estimate free energy differences for molecular systems , 2004, Journal of computational chemistry.
[41] Ying Zhang,et al. Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus , 1996, Nature Medicine.
[42] Ji-Long Zhang,et al. Theoretical improvement of the specific inhibitor of human carbonic anhydrase VII , 2011, Comput. Biol. Chem..
[43] M. Watarai,et al. Brucella abortus nicotinamidase (PncA) contributes to its intracellular replication and infectivity in mice. , 2004, FEMS microbiology letters.
[44] D S Chauhan,et al. The paradox of pyrazinamide: an update on the molecular mechanisms of pyrazinamide resistance in Mycobacteria. , 2006, The Journal of communicable diseases.